Lapis Lazuli International

Lapis Lazuli International is a specialized clinical trial services company that provides global comparator sourcing, clinical packaging, and distribution solutions. Based in the Netherlands, the firm supports pharmaceutical and biotechnology companies in managing the logistical complexities of international clinical trials. Their core expertise lies in regulatory compliance, cold chain management, and the procurement of reference medicinal products. The company operates with a focus on ensuring the integrity and timely delivery of clinical supplies across diverse geographic regions. In 2018, the company was acquired by Caligor Coghlan, expanding its reach as part of a global pharma services platform. Today, it functions as a key European hub for its parent organization's clinical supply chain operations.